Boston Scientific Pilot MDS III Lead - 1st shift 

United States, Minnesota, Maple Grove 

233410913

Your responsibilities will include:

• Work independently with limited direction.
• Must have the ability to write as well as verbally communicate inputs/outputs.
• Work directly with project leads, engineering leads, technicians as well as outside vendors.
• Attend project team/build meetings.
• Adjust their schedule based on project needs.
• Adjust their schedule based on space and machine availability.
• Keep a detailed Artemis tracking project time/times (some work on multiple projects).
  

Required qualifications:

• 4 years with high school diploma/degree/equivalent
• Previous trainer experience or shift lead in production.
• Must be willing to work with devices coated with active pharmaceutical ingredients.
• Must be willing to be mobile and on feet for long periods.

Preferred qualifications:

• Experience using computers and the Windows operating system.
• SAP experience

Among other requirements, Boston Scientific maintains specific prohibited substance testing requirements for safety-sensitive positions. This role is deemed safety-sensitive and, as such, candidates will be subject to a drug test as a pre-employment requirement. The goal of the drug testing is to increase workplace safety in compliance with the applicable law.

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.